TNFRSF13B基因功能获得性突变是家族性或散发性免疫性血小板减少症易感性的候选因素
研究对两个家族性免疫性血小板减少症(ITP)家系进行基因表达谱分析和全外显子测序,发现TNFRSF13B基因p.G76S杂合突变。该突变携带者显示细胞因子-细胞因子受体相互作用信号上调、血清TNFα、IL-17α、IFNγ和BAFF水平升高、APRIL配体与B细胞结合能力增强;携带G76S突变的EBV转化B细胞可显著诱导人巨核细胞系Meg-01凋亡。结论认为p.G76S是ITP的遗传易感因素。
要点
- 全外显子测序在家族性ITP患者中鉴定出TNFRSF13B基因p.G76S杂合突变。
- G76S突变携带者血清TNFα、IL-17α、IFNγ和BAFF水平升高,APRIL与B细胞结合能力增强。
- 携带G76S突变的EBV转化B细胞可显著诱导人巨核细胞系Meg-01凋亡。
核心结论
- TNFRSF13B基因p.G76S突变是ITP的遗传易感因素,与家族性或散发性ITP相关。
研究设计与样本
- 基于一个ITP家系,对家族性ITP患者、散发性ITP病例及健康个体样本进行基因表达谱分析和全外显子测序,并评估潜在致病突变对免疫功能和巨核细胞凋亡的影响。
主要发现
- 全外显子测序在家族性ITP患者中鉴定出TNFRSF13B基因p.G76S杂合突变。
- 携带G76S突变的ITP患者显示细胞因子-细胞因子受体相互作用信号上调,血清TNFα、IL-17α、IFNγ和BAFF水平升高,APRIL配体与B细胞结合能力增强。
- 携带G76S突变的EBV转化B细胞可显著诱导人巨核细胞系Meg-01凋亡。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Essentials Positive family histories suggest the existence of hereditary immune thrombocytopenia (ITP). The predisposing gene for familial ITP was screened in two familial ITP patients. The G76S mutation on TNFRSF13B led to immune dysfunction and induced megakaryocyte apoptosis. The G76S mutation on TNFRSF13B is a gain-of-function mutation and a predisposing variant for ITP. SUMMARY: Background Most immune thrombocytopenia (ITP) is sporadic but a positive family history of ITP in some patients suggests that hereditary forms exist. Because of the rarity of familial ITP families available for study and the heterogeneity of sporadic ITP, family linkage analysis or genome-wide association studies are limited. Objectives Based on one ITP pedigree, we try to identify the predisposing gene in familial or sporadic ITP and reveal the way in which it causes thrombocytopenia. Methods Gene expression profiling analysis and whole-exome sequencing were performed on samples from family members with ITP, sporadic ITP cases and healthy individuals. We also evaluated the influence of potential pathogenic mutation on immune function and megakaryocyte apoptosis. Results Whole-exome sequencing identified a potential pathologic p.G76S heterozygous mutation on the TNFRSF13B gene in familial ITP patients. ITP patients harboring the G76S mutation displayed an upregulated 'cytokine-cytokine receptor interaction' signal, increased serum TNFα, IL-17α, IFNγ and BAFF levels, and enhanced binding capacity of APRIL ligand to B cells. Additionally, Epstein-Barr virus (EBV)-transformed B cells with the G76S mutation could induce human megakaryocyte line (Meg-01) apoptosis significantly. Conclusion p.G76S mutation on the TNFRSF13B gene is responsible for ITP, and is a genetic predisposing factor for familial or sporadic ITP.
引用
- Peng HL, Zhang Y, Sun NN, et al. A gain-of-function mutation in TNFRSF13B is a candidate for predisposition to familial or sporadic immune thrombocytopenia. J Thromb Haemost. 2017. PMID: 28834165. doi:10.1111/jth.13806
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。